These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5860963)

  • 41. [Reactogenic and immunogenic properties of a live measles vaccine made from the Leningrad-16 strain administered via the upper respiratory tract].
    Taros LIu; Smorodintsev AA
    Tr Inst Im Pastera; 1985; 62():75-8. PubMed ID: 3843367
    [No Abstract]   [Full Text] [Related]  

  • 42. [Basic trends and results of active immunization against measles].
    Smorodintsev AA; Boĭchuk LM; Taros LIu; Shikina ES
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():7-35. PubMed ID: 5860965
    [No Abstract]   [Full Text] [Related]  

  • 43. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Data on active immunization against measles in the city of Odessa and in the Odessa region].
    Irodoĭ MA; Bogdanova AP; Levenshtam MA; Shvets NG; Angeli-Baĭbarova RN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():379-84. PubMed ID: 5863068
    [No Abstract]   [Full Text] [Related]  

  • 45. [Electroencephalographic and clinical observations in active measles vaccination with attenuated live vaccine].
    Müller K; Eckoldt G
    Dtsch Gesundheitsw; 1966 Jan; 21(2):70-6. PubMed ID: 5940860
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical data on reactogenic properties of measles vaccines].
    Kuz'micheva AT
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():121-30. PubMed ID: 5860935
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical and immunological prospective study of the measles live virus vaccine].
    Sujoy E; Blaksley JC; Shepherd G; Simsolo V; Palais L; Pizzia A; Becker D; Behar M; Morgenstern O
    Arch Argent Pediatr; 1966; 63(7):260-5. PubMed ID: 5990418
    [No Abstract]   [Full Text] [Related]  

  • 48. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Live measles vaccine from the highly attenuated E. Sch. Ch. (Edmonston-Schwartz-Chmakov) strain, as prepared in the Institute of Poliomyelitis and Virus Encephalitis of the Academy of Medical Sciences of the USSR].
    Chumakov MP; Voroşilova MK; Gracev VP; Dzagurov SG; Sineak KM
    Arch Roum Pathol Exp Microbiol; 1968 Mar; 27(1):17-32. PubMed ID: 5706444
    [No Abstract]   [Full Text] [Related]  

  • 51. [Controlled observation on the incidence of disease and post-vaccinal reactions in children during the three-week period following the beginning of vaccination with live measles vaccine developed by the Academy of Medical Sciences of the USSR from strain EShCh].
    Siniak KM; Chumakov MP; Voroshilova MK; Livanova LV; Zlatkovskaia NM; Ralko LP; Rodin VI; Bulyga MS; Boĭko VM; Karaseva IA; Maksumov SS; Dzhalalov KhD; Varsanova EIa; Miasnikova DE; Makhmudov OS
    Vopr Virusol; 1967; 12(4):406-15. PubMed ID: 5611746
    [No Abstract]   [Full Text] [Related]  

  • 52. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Measles vaccination by the aerosol method in Mexico].
    Fernández-de Castro J; Kumate-Rodríguez J; Sepúlveda J; Ramírez-Isunza JM; Valdespino-Gómez JL
    Salud Publica Mex; 1997; 39(1):53-60. PubMed ID: 9092098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles vaccination: a review.
    Oberman JW
    GP; 1967 May; 35(5):106-7. PubMed ID: 6046507
    [No Abstract]   [Full Text] [Related]  

  • 55. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 57. A case control study to assess the efficacy of measles vaccine.
    Rajapaksa L
    Ceylon Med J; 1993 Dec; 38(4):178-80. PubMed ID: 8143333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seroconversion after measles vaccination in infants and children.
    Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
    J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
    [No Abstract]   [Full Text] [Related]  

  • 60. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.